FDA Adverse Event Injury Summary report: N

AXOZ QUICKSET

MDR report key: 3294671 · Received August 13, 2013

Report

Report Number
3006761298-2013-00005
Event Type
Injury
Date Received
August 13, 2013
Report Date
August 8, 2013
Manufacturer
GRAFTYS
Product Code
MQV
PMA / PMN Number
K093343
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE INFORMATION COLLECTED IS BEING ANALYZED. THE SURGEON WHO DID THE SURGERY HAS RE-OPERATED THE PATIENT BECAUSE OF THE SUBGALEAL HEMORRHAGE, WHICH IS AN EXPECTED ADVERSE EVENT FOR THIS SURGICAL PROCEDURE REGARDLESS OF THE PRODUCT USED FOR FILLING THE CRANIAL DEFECT. THERE IS NO EVIDENCE THAT THE DEVICE IS THE CAUSE OF THE EVENT. IN ADDITION, THE PATIENT WAS (B)(6) YEARS OLD AND IT IS MENTIONED IN THE AXOZ QUICKSET IFU THAT "THE SAFETY AND EFFICACY OF AXOZ QUICKSET HAVE NOT BEEN ESTABLISHED IN THE FOLLOWING POPULATIONS: PATIENTS NOT HAVING REACHED BONE MATURITY." THE NECESSARY PROFESSIONAL INFORMATION WAS REITERATED TO THE USERS BY THE DISTRIBUTOR TO MAKE SURE THAT THE PRODUCT IS USED PROPERLY AND FOR THE RIGHT PATIENT.

Description of Event or Problem · 1

ONE OF OUR DISTRIBUTOR RELATED TO US THE FOLLOWING SITUATION: THE PATIENT WAS OPERATED FOR A CRANIOPLASTY REMODELLING DEFECT. THE SURGEON USED THE AXOZ DEVICE (16CC), BUT HE ONLY USED 8CC OF THE PRODUCT. HE WAITED UNTIL THE PRODUCT SET QUITE HARD AND USED 2 MINIPLATES TO FIX TO THE BONE. SURGEON WAS VERY HAPPY WITH THE IMMEDIATE SURGICAL POST-OP. AFTER 10 DAYS, THE PATIENT HAD AN SUBGALEAL HEMORRHAGE AND THE SURGEONS DECIDED TO RE-OPERATE. THE AXOZ DEVICE LOOKED LIKE SAND IN THE MIDDLE, BUT THE EDGES WERE OK. HE FINALLY USED A BONE CEMENT/AUTOLOGOUS BONE TO TREAT THE PATIENT DEFECT. NO MORE PROBLEMS WERE REPORTED AFTER THE REVISION SURGERY. THIS SITUATION OCCURRED IN (B)(6).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
388129 AXOZ QUICKSET GRAFTYS QUICKSET (K093343) MQV GRAFTYS 4922016 GQS3120613

Patients

Seq Age Sex Outcome Treatment
1 14 YR Required Intervention NOT COMMUNICATED.